Revenue: As of FY2025 Q2, the actual value is USD 56.22 M.EPS: As of FY2025 Q2, the actual value is USD 0.18.<h3>Asset Management</h3><ul><li>Revenue: Asset management revenue increased by $8,556,988, or 4176.4%, for the three months ended June 30, 2025 compared to the same period in 2024, mainly due to the Carlisle Acquisition and FCF Acquisition.</li><li>Cost of Revenue: Increased by $2,878,422, or 1706.5%, for the three months ended June 30, 2025 compared to the same period in 2024, primarily due to the Carlisle Acquisition and FCF Acquisition.</li><li>Gross Profit: Increased by $5,678,566, or 15679.3%, for the three months ended June 30, 2025 compared to the same period in 2024.</li></ul><h3>Life Solutions</h3><ul><li>Revenue: Life solutions revenue increased by $18,429,630 or 63.8% for the three months ended June 30, 2025 compared to the same period in 2024, mainly due to an increase of $49,641,418 in realized gains.</li><li>Cost of Revenue: Decreased by - $64,318, or - 2.5% for the three months ended June 30, 2025 compared to the same period in 2024, mainly due to a decrease in origination related services.</li><li>Gross Profit: Increased by $18,493,948, or 70.3%, for the three months ended June 30, 2025 compared to the same period in 2024.</li></ul><h3>Technology Services</h3><ul><li>Revenue: Technology services revenue increased by $161,900 for the three months ended June 30, 2025 compared to the same period in 2024, mainly due to technology service revenue activity having commenced in December 2024.</li><li>Cost of Revenue: Increased by $497,006 for the three months ended June 30, 2025 compared to the same period in 2024, mainly due to compensation expenses.</li><li>Gross Loss: Increased by $335,106 for the three months ended June 30, 2025 compared to the same period in 2024.</li></ul><h3>Future Outlook</h3><ul><li>Core Business Focus: The Company expects to complete an acquisition of an insurance brokerage firm during the third quarter of 2025, using a note receivable outstanding of approximately $9.0 million as consideration.</li><li>Non-Core Business: The Company announced the commencement of an exchange offer relating to its outstanding Public Warrants and Private Placement Warrants to purchase shares of the Company’s common stock, offering up to an aggregate of 4,743,381 shares of common stock in exchange for the warrants.</li></ul>

Abacus Life - CW27 | 10-Q: FY2025 Q2 Revenue: USD 56.22 M